David W. OwenPartnerBradley Arant Boult Cummings LLPWebsitewww.bradley.com/Organization ProfileFull ProfileConnectEmail205-521-8333 Professional Biography David Owen has 30 years of experience in the construction and engineering industries. He serves as the practice group leader for Bradley’s Construction Practice Group. More Legal and Business Bylines From David W. Owen Alabama Supreme Court Overturns Directed Verdict in Workplace Injury Lawsuit - (Posted On Thursday, November 14, 2024) The Finality of Arbitration: Supreme Court of South Carolina Curbs Arbitration Panel’s Authority - (Posted On Monday, June 24, 2024) How to Deal with Retainage on Alabama Public Projects - (Posted On Thursday, October 26, 2023) Current Legal Analysis Biomanufacturing Interagency Working Group Identifies Actions to Increase U.S. Biomanufacturing Capacity by: Lynn L. Bergeson , Carla N. Hutton Louisiana Court Clarifies Employee Non-Solicitation Provision Requirements by: Joseph F. Lavigne ECHA and Five National Authorities Issue Progress Update on REACH Restriction by: Lynn L. Bergeson , Carla N. Hutton OFCCP Issues First FY 2025 CSAL, Targeting 2,000 Establishments of Supply and Service Federal Contractors and Subcontractors for Audits by: T. Scott Kelly , Lauren B. Hicks California Voters Reject Statewide $18 Minimum Wage for All Employees by: Charles L. Thompson, IV , Zachary V. Zagger EPA Extends Deadline for Public Comment on Manufacture of Certain PFAS during Fluorination of HDPE and Other Plastic Containers by: Lynn L. Bergeson , Carla N. Hutton Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Print
